BLRX fundamentals
An in-depth look to BIOLINE RX operating, investing, and financing activities
BLRX free cash flow for Q4 23 is 16.6 M ILS. For 2023, BLRX free cash flow was -83.81 M ILS and operating cash flow was -83.38 M ILS.
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
0.00
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: ILS
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
TTM